Literature DB >> 15265882

Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation.

Jennifer L Fallas1, Helen M Tobin, Olivia Lou, Donglin Guo, Derek B Sant'Angelo, Lisa K Denzin.   

Abstract

The MHC class II-like molecule HLA-DM (DM) (H-2M in mice) catalyzes the exchange of CLIP for antigenic peptides in the endosomes of APCs. HLA-DO (DO) (H-2O in mice) is another class II-like molecule that is expressed in B cells, but not in other APCs. Studies have shown that DO impairs or modifies the peptide exchange activity of DM. To further evaluate the role of DO in Ag processing and presentation, we generated transgenic mice that expressed the human HLA-DOA and HLA-DOB genes under the control of a dendritic cell (DC)-specific promoter. Our analyses of DCs from these mice showed that as DO levels increased, cell surface levels of A(b)-CLIP also increased while class II-peptide levels decreased. The presentation of some, but not all, exogenous Ags to T cells or T hybridomas was significantly inhibited by DO. Surprisingly, H-2M accumulated in DO-expressing DCs and B cells, suggesting that H-2O/DO prolongs the half-life of H-2M. Overall, our studies showed that DO expression impaired H-2M function, resulting in Ag-specific down-modulation of class II Ag processing and presentation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265882     DOI: 10.4049/jimmunol.173.3.1549

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers.

Authors:  Nicole A Draghi; Lisa K Denzin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-31       Impact factor: 11.205

2.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

3.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Authors:  Padma P Nanaware; Mollie M Jurewicz; John D Leszyk; Scott A Shaffer; Lawrence J Stern
Journal:  Mol Cell Proteomics       Date:  2018-12-20       Impact factor: 5.911

4.  Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob.

Authors:  Lisa K Denzin; Aly A Khan; Francesca Virdis; Jessica Wilks; Melissa Kane; Helen A Beilinson; Stanislav Dikiy; Laure K Case; Derry Roopenian; Michele Witkowski; Alexander V Chervonsky; Tatyana V Golovkina
Journal:  Immunity       Date:  2017-08-15       Impact factor: 31.745

5.  TLR agonists downregulate H2-O in CD8alpha- dendritic cells.

Authors:  Gavin W Porter; Woelsung Yi; Lisa K Denzin
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

6.  Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83): comparison of naïve, vaccine responder and nonresponder to TC-83 challenge in human peripheral blood mononuclear cells.

Authors:  Rebecca Erwin-Cohen; Aimee Porter; Phillip Pittman; Cynthia Rossi; Luis Dasilva
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

Review 7.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

8.  Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.

Authors:  Woelsung Yi; Nilufer P Seth; Tom Martillotti; Kai W Wucherpfennig; Derek B Sant'Angelo; Lisa K Denzin
Journal:  J Clin Invest       Date:  2010-04       Impact factor: 14.808

9.  Exploring the diabetogenicity of the HLA-B18-DR3 CEH: independent association with T1D genetic risk close to HLA-DOA.

Authors:  I Santin; A Castellanos-Rubio; A M Aransay; G Gutierrez; S Gaztambide; I Rica; J L Vicario; J A Noble; L Castaño; J R Bilbao
Journal:  Genes Immun       Date:  2009-05-21       Impact factor: 2.676

Review 10.  MHC class II antigen presentation and immunological abnormalities due to deficiency of MHC class II and its associated genes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Exp Mol Pathol       Date:  2008-04-13       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.